ABSTRACT The current study on GINA Guidelines, drug consumption, prescribing patterns, and comorbidity profiles in patients with bronchial asthma offers important information about asthma management techniques and current prescribing trends. Patients were classified with mild asthma and were well controlled, indicating excellent symptom management. Partial adherence to GINA standards was demonstrated by the preference for inhalation over oral and injection methods. This study mainly focuses on treatment with GINA. Medications, Drug Utilization patterns. The most often given medications were salbutamol and budesonide with ipratropium bromide, indicating a preference for combination therapy to improve Broncho dilation and alleviate symptoms. Brand-name prescribing was more common than generic prescribing, which may increase treatment expense and impact patient compliance .Sleep Apnea, Allergic Rhinitis, Rheumatoid Arthritis, Obesity, TB, GERD, and LRTI. The study emphasizes the necessity of rational prescribing, patient education, consistent prescription monitoring, and better adherence to standard treatment protocols. Active involvement of clinical pharmacists can further improve asthma control, reduce exacerbations, and enhance overall quality of patient care.
Shaik et al. (Fri,) studied this question.